IRIS
CASTELLI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.295
AS - Asia 2.140
SA - Sud America 1.530
EU - Europa 596
Continente sconosciuto - Info sul continente non disponibili 114
AF - Africa 92
OC - Oceania 4
Totale 7.771
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.137
BR - Brasile 1.350
SG - Singapore 944
CN - Cina 373
VN - Vietnam 274
HK - Hong Kong 218
IT - Italia 165
FR - Francia 96
AR - Argentina 78
DE - Germania 68
MX - Messico 63
FI - Finlandia 49
GB - Regno Unito 45
IN - India 42
CA - Canada 41
TR - Turchia 40
BD - Bangladesh 32
IQ - Iraq 30
RU - Federazione Russa 29
ZA - Sudafrica 29
JP - Giappone 27
CO - Colombia 26
EC - Ecuador 26
ID - Indonesia 21
UA - Ucraina 21
UZ - Uzbekistan 21
MA - Marocco 20
SE - Svezia 20
PL - Polonia 18
VE - Venezuela 16
ES - Italia 15
AT - Austria 14
JO - Giordania 14
PY - Paraguay 12
AZ - Azerbaigian 11
PK - Pakistan 11
KE - Kenya 10
CZ - Repubblica Ceca 9
AE - Emirati Arabi Uniti 8
CL - Cile 8
DO - Repubblica Dominicana 8
DZ - Algeria 8
HN - Honduras 8
JM - Giamaica 8
NL - Olanda 8
NP - Nepal 8
PH - Filippine 7
RS - Serbia 7
TN - Tunisia 7
CR - Costa Rica 6
IL - Israele 6
KR - Corea 6
KZ - Kazakistan 6
SA - Arabia Saudita 6
UY - Uruguay 6
EG - Egitto 5
LB - Libano 5
TT - Trinidad e Tobago 5
AL - Albania 4
AU - Australia 4
GE - Georgia 4
LT - Lituania 4
PE - Perù 4
SV - El Salvador 4
AM - Armenia 3
BE - Belgio 3
BO - Bolivia 3
CH - Svizzera 3
CI - Costa d'Avorio 3
GT - Guatemala 3
IE - Irlanda 3
KG - Kirghizistan 3
MY - Malesia 3
PA - Panama 3
SN - Senegal 3
BB - Barbados 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
CY - Cipro 2
HU - Ungheria 2
IR - Iran 2
KW - Kuwait 2
NI - Nicaragua 2
OM - Oman 2
PR - Porto Rico 2
RO - Romania 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
BZ - Belize 1
CG - Congo 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
HR - Croazia 1
KH - Cambogia 1
KY - Cayman, isole 1
LK - Sri Lanka 1
Totale 7.644
Salva come PNG Salva come JPEG
Città #
Dallas 1.356
Singapore 495
San Jose 284
Chandler 229
Hong Kong 213
Ashburn 170
Princeton 138
Council Bluffs 122
Beijing 109
Ho Chi Minh City 100
Columbus 98
São Paulo 87
Lauterbourg 80
New York 79
Shanghai 46
Rio de Janeiro 45
Hanoi 42
Los Angeles 41
Santa Clara 38
Belo Horizonte 34
Helsinki 33
Milan 32
Brasília 30
Tokyo 27
Curitiba 22
Da Nang 21
Orem 21
Munich 18
Warsaw 17
Tashkent 16
Baghdad 15
Goiânia 15
Sassari 15
Campinas 14
Johannesburg 14
Mexico City 14
Porto Alegre 14
Ribeirão Preto 14
Stockholm 14
Amman 13
Chennai 13
Denver 13
Frankfurt am Main 13
Guarulhos 13
Montreal 13
Nuremberg 13
Atlanta 12
Falkenstein 12
Fortaleza 12
Haiphong 12
Santo André 12
São José dos Campos 12
Brooklyn 11
Duque de Caxias 11
Phoenix 11
Poplar 11
The Dalles 11
Baku 10
Nairobi 10
Sorocaba 10
Tianjin 10
Düsseldorf 9
Franca 9
Quito 9
Turku 9
Bogotá 8
Campo Grande 8
Cape Town 8
Dhaka 8
Joinville 8
London 8
Petrópolis 8
Recife 8
Vienna 8
Amsterdam 7
Ankara 7
Asunción 7
Betim 7
Brno 7
Casablanca 7
Guayaquil 7
Houston 7
Istanbul 7
Juiz de Fora 7
Maceió 7
Manaus 7
Medellín 7
Olbia 7
Querétaro 7
Shenzhen 7
São Gonçalo 7
Catanduva 6
Caxias do Sul 6
Conselheiro Lafaiete 6
Contagem 6
Cotia 6
Cuiabá 6
Hải Dương 6
Itapevi 6
Lahore 6
Totale 4.711
Salva come PNG Salva come JPEG
Nome #
Impact of recombinant erythropoietin on anemia, physical function, and cognitive assessment in hospitalized older adults 372
Acquired Hemophilia A after SARS-CoV-2 Immunization: A Narrative Review of a Rare Side Effect 225
Case Report: Dangerous liaisons between splenectomy and eltrombopag-induced chronic thromboembolic pulmonary hypertension in patients with immune thrombocytopenia: report of two cases and review of the literature 177
A Diagnostic of Acquired Hemophilia Following PD1/PDL1 Inhibitors in Advanced Melanoma: The Experience of Two Patients and a Literature Review 167
ADAMTS13, von Willebrand Factor, Platelet Microparticles, Factor VIII, and Impact of Somatic Mutations in the Pathogenesis of Splanchnic Vein Thrombosis Associated with BCR-ABL-Negative Myeloproliferative Neoplasms 149
Brachial Tunneled Peripherally Inserted Central Catheters and the Risk of Catheter Complications: A Systematic Review and Meta-Analysis 146
Aging of the Arterial System 142
Angioedema due to acquired C1-inhibitor deficiency : a bridging condition between autoimmunity and lymphoproliferation 133
Cancer and thromboembolism: from biology to clinics 131
Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management 121
Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants 120
Common Variable Immunodeficiency and Selective IgA Deficiency: Focus on Autoimmune Manifestations and Their Pathogenesis 116
Bendamustine and Rituximab, as First Line Treatment, in Intermediate, High Risk Splenic Marginal Zone Lymphomas of Elderly Patients 115
Biosimilar epoetin alfa increases haemoglobin levels and brings cognitive and socio-relational benefits to elderly transfusion-dependent multiple myeloma patients: results from a pilot study 115
Sodium–Glucose Cotransporter-2 Inhibitors After Acute Myocardial Infarction 111
Choosing treatment options for patients with relapsed/refractory multiple myeloma 110
Biosimilar epoetin in elderly patients with low risk myelodisplastic syndromes improves anaemia, quality of life and brain function 109
Aggressive natural killer cell leukaemia with a complex karyotype: a case report 108
Abnormal Hemostatic Parameters and Risk of Thromboembolism Among Patients With COVID-19 Infection 108
The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity 105
Acquired C1-inhibitor deficiency and lymphoproliferative disorders : a tight relationship 104
Immunomodulatory drugs : new options for the treatment of myelodysplastic syndromes 101
Current and Emerging Treatment Options for Patients with Relapsed Myeloma 100
Incidence of Venous Thromboembolism in Multiple Myeloma Patients across Different Regimens: Role of Procoagulant Microparticles and Cytokine Release 99
Bendamustine in association with rituximab for first-line treatment of diffuse large B-cell lymphoma in frail patients ineligible for R-CHOP/R-CHOP-like treatments 97
Aggressive natural killer cell leukaemia with a complex karyotype: a case report 96
Prothrombotic and inflammatory markers in elderly patients with non-alcoholic hepatic liver disease before and after weight loss: A pilot study 93
Anti-t-PA antibodies in acute myocardial infarction after thrombolysis with rt-PA 91
Ferric Carboxymaltose and Erythropoiesis-Stimulating Agent Treatment Reduces the Rate of Blood Transfusion in Refractory Anemia 90
Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update 89
Midline peripheral catheters inserted in the superficial femoral vein at mid-thigh: Wise choice in COVID-19 acute hypoxemic respiratory failure patients with helmet continuous positive airway pressure 89
Endocrine Side Effects in Patients Treated with Immune Checkpoint Inhibitors: A Narrative Review 87
Splenic marginal zone lymphomas in acquired C1-inhibitor deficiency : clinical and molecular characterization 87
Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies : from pathophysiology to the clinic 86
Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia 86
Complement Activation in Patients With Immune Thrombocytopenic Purpura According to Phases of Disease Course 85
The heparins and cancer: review of clinical trials and biological properties 85
First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomas 84
Neutrophilic progression in a case of polycytemia vera mimicking chronic neutrophilic leukemia: clinical and molecular characterization 83
Inflammatory and prothrombotic parameters in normotensive non-diabetic obese women : effect of weight loss obtained by gastric banding 81
Effect of hydroxyurea on extramedullary haematopoiesis in thalassaemia intermedia : case reports and literature review 81
Management of anaemia in onco-haematological patients treated with biosimilar epoetin alfa: results of an Italian observational, retrospective study 81
Successful management with intravenous immunoglobulins in alemtuzumab-induced acute inflammatory demyelinating neuropathy : clinical report of three patients 80
Does Outcome/Survival of Patients With Myelodysplastic Syndromes Should Be Predicted by Reduced Levels of ADAMTS-13? Results From a Pilot Study 80
The impact of an aging population on the diagnosis of pulmonary embolism: comparison of young and elderly patients 80
Salvage therapy with bortezomib and dexamethasone in elderly patients with relapsed/refractory multiple myeloma 76
Interaction of C1 inhibitor with thrombin on the endothelial surface 76
High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation 76
Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Patients with Heart Failure: An Update 74
The value of four-detector row spiral computed tomography for the diagnosis of pulmonary embolism 74
Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects 74
Platelet Microvesicles, Inflammation, and Coagulation Markers: A Pilot Study 73
Risk Of Thrombosis In Elderly Immune Primary Trombocytopenic Patients Treated With Thrombopoietin Receptors Agonists 73
High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibtor deficiency 73
Clinical Characteristics and treatment outcome of an 86-year old patient with acute myeloid leukemia with acute promyelocytic - like morphology and uncommon RARA fusion variant 73
Transmission of hepatitis G virus in patients with angioedema treated with steam-heated plasma concentrates of C1 inhibitor 73
Possible Effect of Polycystic Ovary Syndrome (PCOS) on Cardiovascular Disease (CVD): An Update 72
Immunomodulatory drugs in multiple myeloma : from molecular mechanisms of action to clinical practice 71
Concomitant use of Tyrosine-Kinase Inhibitor and Mepolizumab in Asthma Secondary to Chronic Myeloid Leukemia with Hypereosinophilia 70
Unusual severe development of common B lymphoblastic leukemia in Gaucher disease type I 68
Thrombosis and hemostatic Abnormalities in haematological malignancies 68
The impact of anaemia, transfusion dependency, commorbidities and polypharmacy in elderly patients with low-risk myelodysplastic syndromes 67
Rheumatoid factors : clinical applications 67
Thromboembolic complications in malignant haematological disorders 67
Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients 67
Ibrutinib related bleeding complications in elderly patients with B cell malignancies 66
Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical praticeguidelineupdate 65
Syncope in patients with pulmonary embolism: comparison between patients with syncope as the presenting symptom of pulmonary embolism and patients with pulmonary embolism without syncope 65
Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis 65
Massive Right Atrial Thrombosis: Are You Brave Enough to Start Anticoagulation? A Case Report 64
Hiv-Related Lymphoprolipherative Diseases In The Era Of Combination Antiretroviral Therapy 62
Integrated short peripheral intravenous cannulas and risk of catheter failure: A systematic review and meta-analysis 61
Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate 61
Intrathoracic masses due to extramedullary hematopoiesis 59
Increased risk of heparin induced thrombocytopenia and thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation 58
High rate of hepatitis B viral breakthrough in elderly non-Hodgkin lymphomas patients treated with Rituximab based chemotherapy 58
Personalized treatment strategies for elderly patients with myelodysplastic syndromes 57
Eltrombopag treatment for thrombocytopenia in myelodysplastic syndromes: differences between responding and non-responding patients—a pilot study 55
New antithrobotic agents 54
Managment of anemia in low risk myelodysplastic syndromes treated with erythropoiesis-stimulating agents newer and older agents 52
Pulmonary embolism in elderly patients: prognostic impact of the Cumulative Illness Rating Scale (CIRS) on short-term mortality 51
Lymphoproliferative disease and acquired C1 inhibitor deficiency 50
Eltrombopag reduces bleeding complications and the need of platelet transfusions in cirrhotic thrombocytopenic patients subjected to invasive procedures 49
Laboratory and clinical risk assessment to treat myelodysplatic syndromes 45
null 45
Risk-tailored treatment of splenic marginal zone lymphoma 44
Unreliable estimation of HbA due to the presence of Camperdown haemoglobin [beta 104 (G6) Arg --> Ser] 42
High Rate of hepatitis B viral breakthrought in elderly non Hodgkin lymphomas patients treated with Rituximab based chemotherapy 16
Totale 7.771
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.171
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.171
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022200 0 0 0 0 0 0 83 0 3 4 21 89
2022/2023515 69 0 2 85 50 77 0 85 96 8 25 18
2023/2024213 26 22 5 3 8 57 2 10 0 6 17 57
2024/20252.370 10 13 84 24 104 81 169 631 800 294 69 91
2025/20264.151 153 950 831 797 321 175 400 112 121 165 89 37
2026/2027322 88 234 0 0 0 0 0 0 0 0 0 0
Totale 7.771